FDA OKs Genentech Breast Cancer Drug

(MedPage Today) -- A drug antibody conjugate called ado-trastuzumab emtansine (Kadcyla) received FDA approval Friday for HER2-positive, metastatic breast cancer.

Source: MedPage Today Hematology/Oncology - February 23, 2013 Category: Hematology Source Type: news